Skip to playerSkip to main content
  • 15 minutes ago
Fox News reports that researchers at UCLA Health’s Jonsson Comprehensive Cancer Center found that temporarily boosting p53 helped specially prepared immune cells stay stronger and kill more melanoma cells in laboratory experiments. The study, published in Frontiers in Immunology, used the experimental drug navtemadlin on human T cells, and treated cells showed fewer signs of exhaustion. The findings remain early and were tested only on cells in a dish. The report examines T-cell exhaustion, the drug’s effects and what researchers may pursue next.

Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

🗞
News
Transcript
00:00Scientists may have found a way to help immune cells fight cancer for longer, Fox News reports.
00:06Researchers at the UCLA Health Johnson Comprehensive Cancer Center studied a protein called P-FD3.
00:12They found that temporarily boosting it helped prepared immune cells stay stronger.
00:17Those cells killed more melanoma cells in laboratory experiments.
00:21The study was published in Frontiers in Immunology.
00:24It focused on T-cells.
00:25Some cancer treatments take a patient's T-cells, modify them in a lab, and return them to the body.
00:32A challenge is that the cells can become exhausted and less effective.
00:36The team treated human T-cells with an experimental drug called neftimidline.
00:41The treated cells showed fewer signs of exhaustion and had more energy.
00:45Higher doses killed more T-cells, while lower doses worked without losing many healthy cells.
00:50The findings are preliminary, and the experiments used cells in a dish, not patients.
00:56Disclosure.
00:57This video contains stock footage and content created or enhanced using AI-assisted tools.

Recommended